Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $31,551 | $21,513 | $23,344 | $1,429 |
| Dep. & Amort. | $4,865 | $4,864 | $4,856 | $4,862 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,919 | $5,440 | -$3,409 | $8,946 |
| Change in WC | $6,061 | $5,727 | -$24,972 | $22,480 |
| Other Non-Cash | -$3,947 | $6,697 | $1,481 | -$7,603 |
| Operating Cash Flow | $44,449 | $44,241 | $1,300 | $30,114 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$65 | -$98 | -$17 | -$281 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$145,425 | -$91,986 | -$84,692 |
| Inv. Sales/Matur. | $0 | $132,250 | $123,035 | $123,970 |
| Other Inv. Act. | -$13,707 | $0 | $0 | $226 |
| Investing Cash Flow | -$13,772 | -$13,273 | $31,032 | $39,223 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,448 | -$3,430 | -$2,771 | -$3,030 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$9,035 | -$42,564 | -$46,921 | -$21,804 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,993 | $1,600 | $355 | $1,788 |
| Financing Cash Flow | -$10,490 | -$44,394 | -$49,337 | -$23,046 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $20,187 | -$13,426 | -$17,005 | $46,291 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,002 | $66,428 | $83,433 | $37,142 |
| End Cash | $73,189 | $53,002 | $66,428 | $83,433 |
| Free Cash Flow | $44,384 | $44,143 | $1,283 | $30,058 |